Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Focus on Levels of Awareness and Perceptions Regarding hsCRP in Identifying Systemic Inflammation in ASCVD, CKD and Heart Failure Management

NCT07160829 is registered in ClinicalTrials.gov with Novo Nordisk A/S as lead sponsor.

NCT NCT07160829
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT07160829 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Focus on Levels of Awareness and Perceptions Regarding hsCRP in Identifying Systemic Inflammation in ASCVD, CKD and Heart Failure Management
Lead sponsor
Novo Nordisk A/S
Phase
Observational
Overall status
Completed
Start date
September 18, 2025
Completion date
October 30, 2025
Enrollment
608 (actual)
Sites
4

Conditions

As the registry lists them; a condition with its own page is linked.

atherosclerotic cardiovascular disease, chronic kidney disease, heart failure